Michael Venning

2.6k total citations · 1 hit paper
44 papers, 1.9k citations indexed

About

Michael Venning is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Michael Venning has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 18 papers in Pulmonary and Respiratory Medicine and 10 papers in Genetics. Recurrent topics in Michael Venning's work include Vasculitis and related conditions (13 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers) and Renal Diseases and Glomerulopathies (8 papers). Michael Venning is often cited by papers focused on Vasculitis and related conditions (13 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers) and Renal Diseases and Glomerulopathies (8 papers). Michael Venning collaborates with scholars based in United Kingdom, Australia and United States. Michael Venning's co-authors include P. Ackrill, David Goldsmith, L J McWilliam, Lorraine Harper, Patrick Hamilton, David Jayne, Paul Brenchley, Durga Kanigicherla, Edwin P. Kirk and Anna Richards and has published in prestigious journals such as The Lancet, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Michael Venning

43 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis

2017 420 citations David Jayne, Annette Bruchfeld et al. Journal of the American Society of Nephrology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael Venning	970	782	538	323	286	44	1.9k
Stephen P. McAdoo	711 0.7×	1.0k 1.3×	643 1.2×	367 1.1×	474 1.7×	103	2.5k
Évangéline Pillebout	1.1k 1.1×	986 1.3×	362 0.7×	124 0.4×	516 1.8×	65	2.5k
Barbara Seitz‐Polski	1.5k 1.5×	627 0.8×	408 0.8×	204 0.6×	146 0.5×	62	2.2k
Eduardo H. Garin	1.3k 1.3×	309 0.4×	418 0.8×	227 0.7×	323 1.1×	99	2.3k
S. Lobatto	303 0.3×	1.2k 1.6×	538 1.0×	284 0.9×	532 1.9×	25	2.0k
Véronique Baudouin	994 1.0×	244 0.3×	467 0.9×	289 0.9×	137 0.5×	84	1.9k
Markus J. Kemper	1.3k 1.4×	259 0.3×	231 0.4×	330 1.0×	143 0.5×	65	1.9k
J O'donnell	373 0.4×	264 0.3×	380 0.7×	255 0.8×	731 2.6×	62	1.8k
Hideaki Yamabe	577 0.6×	246 0.3×	229 0.4×	143 0.4×	399 1.4×	91	2.0k
Christiane Mousson	795 0.8×	407 0.5×	564 1.0×	122 0.4×	55 0.2×	81	1.8k

Countries citing papers authored by Michael Venning

Since Specialization

Citations

This map shows the geographic impact of Michael Venning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Venning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Venning more than expected).

Fields of papers citing papers by Michael Venning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Venning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Venning. The network helps show where Michael Venning may publish in the future.

Co-authorship network of co-authors of Michael Venning

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Venning. A scholar is included among the top collaborators of Michael Venning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Venning. Michael Venning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tollitt, James, Nikolaos Marketos, Ajay Dhaygude, et al.. (2024). IgA vasculitis nephritis—outcomes in adult-onset disease. Lara D. Veeken. 64(2). 690–696. 4 indexed citations

Jayne, David, Annette Bruchfeld, Lorraine Harper, et al.. (2017). Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis. Journal of the American Society of Nephrology. 28(9). 2756–2767. 420 indexed citations breakdown →

Jayne, David, Annette Bruchfeld, Lorraine Harper, et al.. (2016). MO039SUCCESSFUL STEROID REPLACEMENT IN ANCA-ASSOCIATED VASCULITIS WITH C5A RECEPTOR INHIBITOR CCX168 IN PHASE 2 RANDOMISED TRIAL (CLEAR). Nephrology Dialysis Transplantation. 31(suppl_1). i45–i45. 2 indexed citations

Kanigicherla, Durga, Colin D. Short, Stephen A. Roberts, et al.. (2016). Long-term outcomes of persistent disease and relapse in primary membranous nephropathy. Nephrology Dialysis Transplantation. 31(12). 2108–2114. 25 indexed citations

Jayne, David, Annette Bruchfeld, Matthias Schaier, et al.. (2014). Phase 2 randomised trial of oral C5A receptor antagonist CCX168 in ANCA-associated renal vasculitis. Nephrology Dialysis Transplantation. 29. 4 indexed citations

Croft, Adam P., Stuart W. Smith, Sue Carr, et al.. (2014). Successful outcome of pregnancy in patients with anti-neutrophil cytoplasm antibody–associated small vessel vasculitis. Kidney International. 87(4). 807–811. 20 indexed citations

Hamilton, Patrick, et al.. (2014). Urinary protein selectivity in nephrotic syndrome and pregnancy: resurrection of a biomarker when renal biopsy is contraindicated. Clinical Kidney Journal. 7(6). 595–598. 7 indexed citations

Latimer, Nicholas, Christopher Carroll, Ruth Wong, et al.. (2014). Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal. PharmacoEconomics. 32(12). 1171–1183. 10 indexed citations

Chrysochou, Constantina, Chi-Ngai Cheung, Rachel Middleton, et al.. (2009). Proteinuria as a predictor of renal functional outcome after revascularization in atherosclerotic renovascular disease (ARVD). QJM. 102(4). 283–288. 19 indexed citations

10.

Nicholson, Jay, et al.. (2006). Digestive properties of the venom of the Australian Coastal Taipan, Oxyuranus scutellatus (Peters, 1867). Toxicon. 48(4). 422–428. 9 indexed citations

11.

Smith, Charlotte A., Michael Venning, & Joanna Verran. (2004). Use of novel culture media to indicate alkaligenic properties of dental plaque. Microbial Ecology in Health and Disease. 16(1). 44–50. 4 indexed citations

12.

Richards, Anna, M. Buddles, Rosemary L. Donne, et al.. (2001). Factor H Mutations in Hemolytic Uremic Syndrome Cluster in Exons 18–20, a Domain Important for Host Cell Recognition. The American Journal of Human Genetics. 68(2). 485–490. 254 indexed citations

13.

Wardley, Andrew, et al.. (1998). The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone. British Journal of Cancer. 78(6). 774–776. 27 indexed citations

14.

Covic, Adrian, David Goldsmith, Kylie Hill, Michael Venning, & P. Ackrill. (1998). Urea kinetic modelling - are any of the 'bedside' Kt/V formulae reliable enough?. Nephrology Dialysis Transplantation. 13(12). 3138–3146. 13 indexed citations

15.

Goldsmith, David, Adrian Covic, Michael Venning, & P. Ackrill. (1997). Ambulatory blood pressure monitoring in renal dialysis and transplant patients. American Journal of Kidney Diseases. 29(4). 593–600. 63 indexed citations

16.

Grace, N. D., et al.. (1995). The efficacy of selenium dioxide as a selenium supplement for dairy cattle. New Zealand Veterinary Journal. 43(2). 77–78. 2 indexed citations

17.

Harty, John, Helen Boulton, Janet Curwell, et al.. (1994). The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. Kidney International. 45(1). 103–109. 81 indexed citations

18.

Grace, N. D., Michael Venning, & G Vincent. (1994). An evaluation of a controlled release system for selenium in lambs. New Zealand Veterinary Journal. 42(2). 63–65. 5 indexed citations

19.

Goldsmith, David, et al.. (1994). Lesson of the Week: Acute swollen legs due to rhabdomyolysis: initial management as deep vein thrombosis may lead to acute renal failure. BMJ. 309(6965). 1361–1362. 7 indexed citations

20.

Venning, Michael, et al.. (1990). Antibodies Directed Against Neutrophils (C-ANCA and P-ANCA) are of Distinct Diagnostic Value in Systemic Vasculitis. QJM. 77(3). 1287–1296. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact